DMIIR — Drugs Made In America Acquisition II Corp.

—
Nasdaq · Financials · Diversified Financial Services · CIK 2040475 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Mar 2026 4,439,850 0 -132,030 4,337,820 509,725,411 — 18,166,285
Sep 2025 109,355 0 -155,513 -46,158 501,005,711 315,087 18,177,345

Annual Trend (SEC EDGAR, last 1y)

Revenues vs Net Income (last 1y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 4,933,800 -488,385 4,187,050 504,959,837 17,800,864 487,158,973 —

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$509,725,411
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
HASI HA Sustainable Infrastructure Capital, Inc. $4.67B $36.35 —
DMII Drugs Made In America Acquisition II Corp. $649.10M $10.19 —
XRPN Armada Acquisition Corp. II $573.78M $24.20 —
EVAC EQV Ventures Acquisition Corp. II $484.50M $10.32 —
BCSS Bain Capital GSS Investment Corp. $479.79M $10.23 —

News headlines (Yahoo Finance, 1h cache)

NexGen Energy’s Rook I Project Emerges as a Key Source in the Next Uranium Supply Wave
2026-02-24 21:42 · Yahoo
Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is largely controlled by institutional shareholders who own 79% of the company
2025-12-04 15:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.